淋巴结阴性和阳性乳腺癌的预后变量 - Suppr

Suppr

超能文献

Prognostic variables in node-negative and node-positive breast cancer.

作者信息

Gasparini G

出版信息

Breast Cancer Res Treat. 1998;52(1-3):321-31. doi: 10.1023/a:1006102021879.

DOI:10.1023/a:1006102021879

PMID:10066090

Abstract

摘要

相似文献

Prognostic variables in node-negative and node-positive breast cancer.淋巴结阴性和阳性乳腺癌的预后变量

Breast Cancer Res Treat. 1998;52(1-3):321-31. doi: 10.1023/a:1006102021879.

Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.cT1-2 和 cN0 期乳腺癌患者前哨淋巴结转移的预后意义最小。

World J Surg Oncol. 2019 Feb 23;17(1):41. doi: 10.1186/s12957-019-1585-9.

[Prognostic factors in node-negative breast cancer].[腋窝淋巴结阴性乳腺癌的预后因素]

Gynakol Geburtshilfliche Rundsch. 1993;33 Suppl 1:238. doi: 10.1159/000272238.

Prognostic factors for recurrence and survival in axillary node-negative breast cancer.腋窝淋巴结阴性乳腺癌复发和生存的预后因素。

J Steroid Biochem. 1989;34(1-6):145-8. doi: 10.1016/0022-4731(89)90075-7.

The prognostic role of interleukin-8 (IL-8) and matrix metalloproteinases -2 and -9 in lymph node-negative untreated breast cancer patients.白细胞介素-8（IL-8）以及基质金属蛋白酶-2和-9在未接受治疗的淋巴结阴性乳腺癌患者中的预后作用。

J BUON. 2013 Oct-Dec;18(4):866-73.

In stage II/III lymph node-positive breast cancer patients less than 55 years of age, keratin 8 expression in lymph node metastases but not in the primary tumour is an indicator of better survival.在年龄小于55岁的II/III期淋巴结阳性乳腺癌患者中，淋巴结转移灶而非原发肿瘤中的角蛋白8表达是生存情况较好的一个指标。

Virchows Arch. 2015 May;466(5):571-80. doi: 10.1007/s00428-015-1748-1. Epub 2015 Feb 28.

Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.Raf/MEK/ERK信号通路与腋窝淋巴结转移乳腺癌患者临床病理特征及预后的相关性

Technol Cancer Res Treat. 2018 Jan 1;17:1533034617754024. doi: 10.1177/1533034617754024.

Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.p53、血管生成及其他传统特征在可手术乳腺癌中的预后意义：对淋巴结阳性和阴性患者的亚组分析

Int J Oncol. 1998 May;12(5):1117-25. doi: 10.3892/ijo.12.5.1117.

HER2 as a prognostic factor in breast cancer.HER2作为乳腺癌的一个预后因素。

Oncology. 2001;61 Suppl 2:67-72. doi: 10.1159/000055404.

Tumor angiogenesis in node-negative breast carcinomas--relationship with epidermal growth factor receptor, estrogen receptor, and survival.淋巴结阴性乳腺癌中的肿瘤血管生成——与表皮生长因子受体、雌激素受体及生存的关系

Breast Cancer Res Treat. 1994 Jan;29(1):109-16. doi: 10.1007/BF00666186.

引用本文的文献

Chromatin Variants Reveal the Genetic Determinants of Oncogenesis in Breast Cancer.染色质变体揭示乳腺癌发生的遗传决定因素。

Cold Spring Harb Perspect Med. 2022 Oct 3;12(10):a041322. doi: 10.1101/cshperspect.a041322.

Estrogen Receptor Positive and Progesterone Receptor Negative Breast Cancer: the Role of Hormone Therapy.雌激素受体阳性和孕激素受体阴性乳腺癌：激素治疗的作用。

Horm Cancer. 2020 Aug;11(3-4):148-154. doi: 10.1007/s12672-020-00387-1. Epub 2020 Jun 9.

CORRELATIONSHIP OF HORMONE RECEPTOR STATUS, p53 MUTATION AND c-erb B-2 OVEREXPRESSION WITH NUCLEAR GRADING IN BREAST CANCERS.乳腺癌中激素受体状态、p53 突变及 c-erb B-2 过表达与核分级的关系

Med J Armed Forces India. 2000 Oct;56(4):305-308. doi: 10.1016/S0377-1237(17)30215-0. Epub 2017 Jun 12.

Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines.肿瘤标志物预后研究报告：对相关 REMARK 指南的已发表文章的回顾。

Br J Cancer. 2010 Jan 5;102(1):173-80. doi: 10.1038/sj.bjc.6605462. Epub 2009 Dec 8.

REporting recommendations for tumour MARKer prognostic studies (REMARK).肿瘤标志物预后研究报告建议（REMARK）

Br J Cancer. 2005 Aug 22;93(4):387-91. doi: 10.1038/sj.bjc.6602678.

Prognostic factors in breast cancer: current and new predictors of metastasis.乳腺癌的预后因素：转移的当前及新预测指标

J Mammary Gland Biol Neoplasia. 2001 Oct;6(4):375-92. doi: 10.1023/a:1014778713034.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验